Breaking News Instant updates and real-time market news.

AMKR

Amkor Technology

$24.50 /

+0.69 (+2.90%)

14:50
04/26/21
04/26
14:50
04/26/21
14:50

Amkor Technology sees Q2 EPS 32c-52c, one estimate 43c

Sees Q2 revenue $1.29B-$1.39B, one estimate $1.35B. Sees Q2 gross margin of 17%-20%. "We believe the second quarter will be another solid quarter, with revenue of $1.34 billion at the midpoint of our guidance. Our forecast reflects capacity constraints in wafers and substrates that are expected to affect portions of the supply chain in the near term, and we are working closely with our customers and suppliers to mitigate the impact. Overall, we continue to see solid demand across all of our key markets and remain confident that our strong position in Advanced packaging will enable us to outgrow the semiconductor market in 2021," said Giel Rutten, Amkor's president and CEO.

  • 26

    Apr

  • 18

    May

AMKR Amkor Technology
$24.50 /

+0.69 (+2.90%)

02/11/21 Citi
Amkor Technology price target raised to $15 from $13 at Citi
01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
Amkor Technology price target raised to $13 from $11.40 at Citi
11/19/20 Citi
Citi moves Lam Research, Marvell to top picks in Semi Equipment

TODAY'S FREE FLY STORIES

General news
U.S. ADP preview » 01:50
12/01/21
12/01
01:50
12/01/21
01:50
$ECON

Economic Data

/

+

U.S. ADP preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. ISM preview » 01:50
12/01/21
12/01
01:50
12/01/21
01:50
$ECON

Economic Data

/

+

U.S. ISM preview: the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Asian Market Update: » 01:50
12/01/21
12/01
01:50
12/01/21
01:50
$ECON

Economic Data

/

+

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. construction spending preview » 01:50
12/01/21
12/01
01:50
12/01/21
01:50
$ECON

Economic Data

/

+

U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
GB Group upgraded to Buy from Hold at Jefferies » 21:14
11/30/21
11/30
21:14
11/30/21
21:14
GBGPF

GB Group

$12.22 /

+ (+0.00%)

Jefferies analyst Paul…

Jefferies analyst Paul Kratz upgraded GB Group to Buy from Hold with a 1,050 GBp price target. The acquisition of Acuant "marks a step change for the business," as it increases GB's exposure to the ID verification market and offers an end-to-end solution to address growth in the ID verification and fraud market, Kratz tells investors in a research note. The analyst says the deal "marks a positive step change for GB Group following pandemic deal hiatus."

ShowHide Related Items >><<
GBGPF GB Group
$12.22 /

+ (+0.00%)

11/30/21 Stifel
GB Group upgraded to Buy from Hold at Stifel
11/29/21 Barclays
GB Group upgraded to Overweight from Equal Weight at Barclays
11/23/21 Canaccord
GB Group price target lowered to 950 GBp from 1,000 GBp at Canaccord
10/15/21 Canaccord
GB Group upgraded to Buy from Hold at Canaccord
Syndicate
Krystal Biotech 2.67M share Secondary priced at $75.00 » 20:18
11/30/21
11/30
20:18
11/30/21
20:18
KRYS

Krystal Biotech

$80.48 /

-7.525 (-8.55%)

The deal priced below…

The deal priced below last closing price of $80.55. Goldman Sachs, BofA and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
KRYS Krystal Biotech
$80.48 /

-7.525 (-8.55%)

KRYS Krystal Biotech
$80.48 /

-7.525 (-8.55%)

11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 Goldman Sachs
Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs
07/09/21 Chardan
Krystal Biotech coverage transferred at Chardan
KRYS Krystal Biotech
$80.48 /

-7.525 (-8.55%)

  • 01
    Dec
  • 03
    Feb
KRYS Krystal Biotech
$80.48 /

-7.525 (-8.55%)

Hot Stocks
Cathie Wood's ARK Investment bought 837K shares of Robinhood on Tuesday  20:14
11/30/21
11/30
20:14
11/30/21
20:14
HOOD

Robinhood

$25.95 /

-1.16 (-4.28%)

 
ShowHide Related Items >><<
HOOD Robinhood
$25.95 /

-1.16 (-4.28%)

HOOD Robinhood
$25.95 /

-1.16 (-4.28%)

11/19/21 Deutsche Bank
Deutsche Bank opens 'sell Catalyst Call' on Robinhood shares
11/16/21
Fly Intel: Top five analyst downgrades
11/16/21 Atlantic Equities
Atlantic Equities downgrades Robinhood on 'abrupt cessation' of user growth
11/16/21 Atlantic Equities
Robinhood downgraded to Neutral from Overweight at Atlantic Equities
HOOD Robinhood
$25.95 /

-1.16 (-4.28%)

  • 29
    Jul
HOOD Robinhood
$25.95 /

-1.16 (-4.28%)

HOOD Robinhood
$25.95 /

-1.16 (-4.28%)

HOOD Robinhood
$25.95 /

-1.16 (-4.28%)

Hot Stocks
Cathie Wood's ARK Investment bought 1.1M shares of Twitter on Tuesday  20:13
11/30/21
11/30
20:13
11/30/21
20:13
TWTR

Twitter

$43.95 /

-1.81 (-3.96%)

 
ShowHide Related Items >><<
TWTR Twitter
$43.95 /

-1.81 (-3.96%)

TWTR Twitter
$43.95 /

-1.81 (-3.96%)

11/30/21 Jefferies
Twitter leadership changes 'step in right direction,' says Jefferies
11/30/21 Wedbush
Twitter price target lowered to $52 from $69 at Wedbush
11/29/21 Piper Sandler
Twitter CEO change a 'modest positive,' says Piper Sandler
11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
TWTR Twitter
$43.95 /

-1.81 (-3.96%)

TWTR Twitter
$43.95 /

-1.81 (-3.96%)

TWTR Twitter
$43.95 /

-1.81 (-3.96%)

TWTR Twitter
$43.95 /

-1.81 (-3.96%)

Hot Stocks
Cathie Wood's ARK Investment bought 162K shares of Zoom Video on Tuesday  20:10
11/30/21
11/30
20:10
11/30/21
20:10
ZM

Zoom Video

$211.50 /

-7.55 (-3.45%)

 
ShowHide Related Items >><<
ZM Zoom Video
$211.50 /

-7.55 (-3.45%)

ZM Zoom Video
$211.50 /

-7.55 (-3.45%)

11/30/21 Daiwa
Zoom Video upgraded to Underperform from Sell at Daiwa
11/23/21
Fly Intel: Top five analyst downgrades
11/23/21 BofA
Zoom Video downgraded to Neutral from Buy at BofA
11/23/21 Wells Fargo
Zoom Video price target lowered to $245 from $275 at Wells Fargo
ZM Zoom Video
$211.50 /

-7.55 (-3.45%)

  • 13
    Jan
ZM Zoom Video
$211.50 /

-7.55 (-3.45%)

ZM Zoom Video
$211.50 /

-7.55 (-3.45%)

ZM Zoom Video
$211.50 /

-7.55 (-3.45%)

Hot Stocks
Palo Alto Networks CEO sells $5.1M in common stock » 19:25
11/30/21
11/30
19:25
11/30/21
19:25
PANW

Palo Alto Networks

$546.74 /

-4.53 (-0.82%)

In a regulatory filing,…

In a regulatory filing, Palo Alto Networks disclosed that its CEO Nikesh Arora sold 9.4K shares of common stock on November 29th in a total transaction size of $5.1M, reducing his stake by about 2%.

ShowHide Related Items >><<
PANW Palo Alto Networks
$546.74 /

-4.53 (-0.82%)

PANW Palo Alto Networks
$546.74 /

-4.53 (-0.82%)

11/23/21 Argus
Palo Alto Networks price target raised to $620 from $530 at Argus
11/19/21 RBC Capital
Palo Alto Networks price target raised to $660 from $590 at RBC Capital
11/19/21 Truist
Palo Alto Networks price target raised to $600 from $525 at Truist
11/19/21 BMO Capital
Palo Alto Networks price target raised to $615 from $560 at BMO Capital
PANW Palo Alto Networks
$546.74 /

-4.53 (-0.82%)

PANW Palo Alto Networks
$546.74 /

-4.53 (-0.82%)

PANW Palo Alto Networks
$546.74 /

-4.53 (-0.82%)

PANW Palo Alto Networks
$546.74 /

-4.53 (-0.82%)

Syndicate
Aditx Therapeutics files to sell common stock, no amount given » 19:21
11/30/21
11/30
19:21
11/30/21
19:21
ADTX

Aditx Therapeutics

$1.17 /

-0.01 (-0.85%)

Dawson James Securities,…

Dawson James Securities, Inc. is acting as sole book-running manager for the offering.

ShowHide Related Items >><<
ADTX Aditx Therapeutics
$1.17 /

-0.01 (-0.85%)

ADTX Aditx Therapeutics
$1.17 /

-0.01 (-0.85%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Dawson James
Aditx Therapeutics initiated with a Buy at Dawson James
ADTX Aditx Therapeutics
$1.17 /

-0.01 (-0.85%)

Hot Stocks
Community Financial raises dividend 17% to 17.5c » 18:43
11/30/21
11/30
18:43
11/30/21
18:43
TCFC

Community Financial

$36.25 /

-1.25 (-3.33%)

The Community Financial ,…

The Community Financial , the bank holding company for Community Bank of the Chesapeake, announced that its Board of Directors has declared a quarterly cash dividend of 17.5c per share of common stock, up from 15c in the previous quarter. This represents a 17% increase over the previous quarter. The dividend will be paid on or about January 24, 2022 to stockholders of record as of the close of business on January 10, 2022.

ShowHide Related Items >><<
TCFC Community Financial
$36.25 /

-1.25 (-3.33%)

10/28/21
Fly Intel: Top five analyst upgrades
10/28/21 Keefe Bruyette
Community Financial upgraded to Outperform at Keefe Bruyette
02/09/21 Piper Sandler
Community Financial upgraded to Overweight from Neutral at Piper Sandler
02/08/21 Piper Sandler
Community Financial upgraded to Overweight from Neutral at Piper Sandler
TCFC Community Financial
$36.25 /

-1.25 (-3.33%)

TCFC Community Financial
$36.25 /

-1.25 (-3.33%)

Hot Stocks
PayPal CEO: Online is an increasing amount of overall retail today » 18:38
11/30/21
11/30
18:38
11/30/21
18:38
PYPL

PayPal

$185.15 /

-2 (-1.07%)

, EBAY

eBay

$67.49 /

-2.85 (-4.05%)

In an interview on…

In an interview on CNBC's Mad Money, Dan Schulman said PayPal had a "real strong start" coming into November. The company is still on track for 55M net new actives and over 416M people are currently on the platform, he noted. PayPal is already one of the top three or four buy now-pay later players in the world, he added. During Black Friday, volume on buy now-pay later was up almost 400% year over year. Ebay (EBAY) is now less than 3% of TPV and about 3% of revenues, according to Schulman. The company is seeing "consistent strong core performance." It has a very strong balance sheet and will be acquisitive, but has very strict criteria, he noted.

ShowHide Related Items >><<
PYPL PayPal
$185.15 /

-2 (-1.07%)

EBAY eBay
$67.49 /

-2.85 (-4.05%)

PYPL PayPal
$185.15 /

-2 (-1.07%)

11/17/21 UBS
PayPal assumed with a Buy at UBS
11/17/21 UBS
PayPal assumed with a Buy at UBS
11/17/21
Fly Intel: Top five analyst downgrades
11/17/21 Bernstein
PayPal downgraded to Market Perform at Bernstein on risk of being disrupted
EBAY eBay
$67.49 /

-2.85 (-4.05%)

11/23/21
Fly Intel: Top five analyst downgrades
11/22/21 Guggenheim
eBay downgraded to Neutral at Guggenheim upon assumption
11/22/21 Guggenheim
eBay downgraded to Neutral from Buy at Guggenheim
11/22/21 Goldman Sachs
eBay reinstated with a Neutral at Goldman Sachs
PYPL PayPal
$185.15 /

-2 (-1.07%)

EBAY eBay
$67.49 /

-2.85 (-4.05%)

PYPL PayPal
$185.15 /

-2 (-1.07%)

EBAY eBay
$67.49 /

-2.85 (-4.05%)

PYPL PayPal
$185.15 /

-2 (-1.07%)

EBAY eBay
$67.49 /

-2.85 (-4.05%)

PYPL PayPal
$185.15 /

-2 (-1.07%)

EBAY eBay
$67.49 /

-2.85 (-4.05%)

On The Fly
Fly Intel: After-Hours Movers » 18:28
11/30/21
11/30
18:28
11/30/21
18:28
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

, BOX

Box

$23.47 /

-0.73 (-3.02%)

, ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

, NTAP

NetApp

$89.00 /

-2.545 (-2.78%)

, GFS

GlobalFoundries

$69.42 /

-1.05 (-1.49%)

, BBW

Build-A-Bear

$17.01 /

-0.02 (-0.12%)

, MNTS

Momentus

$6.87 /

-0.27 (-3.78%)

, MRK

Merck

$74.87 /

-0.005 (-0.01%)

, LSTR

Landstar System

$168.60 /

-4.02 (-2.33%)

, MA

MasterCard

$314.80 /

-8.18 (-2.53%)

, EMKR

Emcore

$7.40 /

-0.14 (-1.86%)

, CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

, BIRD

Allbirds

$19.33 /

+0.5 (+2.66%)

, HPE

HP Enterprise

$14.38 /

-0.22 (-1.51%)

, LAC

Lithium Americas

$39.33 /

-1.64 (-4.00%)

, IMGN

ImmunoGen

$6.18 /

+1.42 (+29.83%)

Check out this evening's…

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTS Momentus
$6.87 /

-0.27 (-3.78%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

IMGN ImmunoGen
$6.18 /

+1.42 (+29.83%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

EMKR Emcore
$7.40 /

-0.14 (-1.86%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

11/29/21 Morgan Stanley
Ambarella price target raised to $222 from $137 at Morgan Stanley
10/27/21 Needham
Ambarella price target raised to $220 from $140 at Needham
10/27/21 Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
10/27/21 Stifel
Ambarella price target raised to $200 after Oculii deal at Stifel
BOX Box
$23.47 /

-0.73 (-3.02%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 Morgan Stanley
Morgan Stanley downgrades Box on resumption after stock outperformance
10/07/21 Morgan Stanley
Box downgraded to Equal Weight from Overweight at Morgan Stanley
09/27/21
Fly Intel: Top five analyst upgrades
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

11/29/21 Needham
Zscaler price target raised to $390 from $345 at Needham
11/29/21 RBC Capital
Zscaler price target raised to $380 from $326 at RBC Capital
11/24/21 Deutsche Bank
Zscaler price target raised to $400 from $325 at Deutsche Bank
11/16/21 Credit Suisse
Zscaler initiated with an Outperform at Credit Suisse
NTAP NetApp
$89.00 /

-2.545 (-2.78%)

11/24/21 Morgan Stanley
Dell Technologies price target raised to $68 from $67 at Morgan Stanley
10/18/21 Goldman Sachs
NetApp downgraded to Sell from Neutral at Goldman Sachs
10/14/21 Citi
NetApp upgraded to Buy from Sell at Citi
09/29/21 JPMorgan
NetApp price target raised to $108 from $95 at JPMorgan
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

MNTS Momentus
$6.87 /

-0.27 (-3.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
LSTR Landstar System
$168.60 /

-4.02 (-2.33%)

10/22/21 Truist
Landstar System price target raised to $165 from $155 at Truist
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Evercore ISI
Landstar System initiated with an In Line at Evercore ISI
09/13/21 Evercore ISI
Landstar System initiated with an In Line at Evercore ISI
MA MasterCard
$314.80 /

-8.18 (-2.53%)

11/17/21 UBS
UBS assumes coverage of MasterCard with a Buy, citing increasing travel demand
11/17/21 UBS
MasterCard assumed with a Buy at UBS
11/17/21 Cowen
Amazon to stop accepting Visa cards in UK, says Cowen
11/15/21 Mizuho
MasterCard price target raised to $465 from $450 at Mizuho
EMKR Emcore
$7.40 /

-0.14 (-1.86%)

08/05/21 Lake Street
Emcore price target raised to $13 from $8 at Lake Street
05/26/21 Cowen
Cowen starts Emcore at Outperform, sees attractive risk/reward
05/26/21 Cowen
Emcore initiated with an Outperform at Cowen
03/04/21
Fly Intel: Top five analyst initiations
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
11/23/21 Citi
Salesforce price target raised to $308 from $280 at Citi
11/22/21 Atlantic Equities
Atlantic Equities assumes 'low-risk' Salesforce at Overweight
BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
11/29/21 JPMorgan
Allbirds initiated with a Neutral at JPMorgan
HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
09/03/21 Raymond James
HP Enterprise price target raised to $22 from $20 at Raymond James
09/03/21 Wells Fargo
HP Enterprise price target raised to $20 from $18 at Wells Fargo
LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

11/24/21 B. Riley
Lithium Americas price target raised to $44 from $25 at B. Riley
11/22/21 Piper Sandler
Lithium Americas price target raised to $32 from $22 at Piper Sandler
11/19/21 JPMorgan
Lithium Americas price target raised to $39 from $28 at JPMorgan
11/18/21 Canaccord
Lithium Americas price target raised to C$46 from C$35 at Canaccord
IMGN ImmunoGen
$6.18 /

+1.42 (+29.83%)

11/30/21 Piper Sandler
Piper says outlook on ImmunoGen's mirve opportunity 'largely unchanged'
11/30/21 RBC Capital
ImmunoGen price target raised to $9 from $8 at RBC Capital
06/07/21 Piper Sandler
ImmunoGen data largely consistent with prior updates, says Piper Sandler
05/10/21 Piper Sandler
Piper says ImmunoGen's 'modest' timeline slip makes cash runway 'more tenuous'
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LSTR Landstar System
$168.60 /

-4.02 (-2.33%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

IMGN ImmunoGen
$6.18 /

+1.42 (+29.83%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

EMKR Emcore
$7.40 /

-0.14 (-1.86%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

  • 02
    Dec
  • 03
    Nov
  • 28
    Oct
  • 11
    Feb
  • 20
    Jan
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTS Momentus
$6.87 /

-0.27 (-3.78%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Periodicals
U.S. prepares stricter traveler testing amid omicron concerns, WP reports » 18:28
11/30/21
11/30
18:28
11/30/21
18:28
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$455.84 /

-8.8 (-1.89%)

, ALK

Alaska Air

$48.57 /

-0.87 (-1.76%)

, LUV

Southwest

$44.45 /

-0.095 (-0.21%)

, DAL

Delta Air Lines

$36.20 /

-0.03 (-0.08%)

, JBLU

JetBlue

$13.43 /

-0.09 (-0.67%)

, UAL

United Airlines

$42.25 /

-0.295 (-0.69%)

, SAVE

Spirit Airlines

$20.92 /

-0.38 (-1.78%)

, AAL

American Airlines

$17.69 /

-0.05 (-0.28%)

The White House is…

The White House is planning stricter testing requirements for all travelers entering the U.S., including returning U.S. citizens, to hinder the spread of the recently-discovered omicron variant of COVID-19, the Washington Post's Lena Sun and Tyler Pager report, citing three federal health officials. As part of a winter COVID strategy that President Joe Biden intends to unveil later this week, U.S. officials will require everyone entering the country to be tested one day prior to boarding flights, regardless of vaccination status or place of departure, the author says, noting that administration officials are also mulling a requirement that all travelers get retested within three to five days of arrival. Publicly traded companies in the space include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL). Reference Link

ShowHide Related Items >><<
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

SPX S&P 500
/

+

11/26/21 Morgan Stanley
Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
11/26/21 Credit Suisse
Concerns over new Covid variant 'understandable,' says Credit Suisse
11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21 JPMorgan
Alaska Air price target raised to $97 from $94 at JPMorgan
07/20/21 Raymond James
Alaska Air price target lowered to $78 from $85 at Raymond James
07/12/21 Evercore ISI
Volaris price target raised to $30 from $25 at Evercore ISI
LUV Southwest
$44.45 /

-0.095 (-0.21%)

11/19/21
Fly Intel: Top five analyst upgrades
11/19/21 Wolfe Research
Southwest upgraded to Outperform from Peer Perform at Wolfe Research
11/16/21
Fly Intel: Top five analyst downgrades
11/16/21 Goldman Sachs
Southwest downgraded to Neutral from Buy at Goldman Sachs
DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

11/19/21 Wolfe Research
Delta Air Lines upgraded to Outperform from Peer Perform at Wolfe Research
10/29/21 BTIG
Call with Sharecare customers raises BTIG conviction in long-term outlook
10/14/21 Cowen
Delta Air Lines price target raised to $54 from $53 at Cowen
10/14/21 Morgan Stanley
Delta Air Lines price target lowered to $62 from $67 at Morgan Stanley
JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 Exane BNP Paribas
JetBlue upgraded to Neutral from Underperform at Exane BNP Paribas
10/06/21
Fly Intel: Top five analyst downgrades
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

10/21/21 Cowen
United Airlines price target raised to $78 from $72 at Cowen
08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

10/28/21 Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
AAL American Airlines
$17.69 /

-0.05 (-0.28%)

10/06/21 Goldman Sachs
American Airlines downgraded to Sell from Neutral at Goldman Sachs
08/11/21 Redburn
American Airlines initiated with a Buy at Redburn
07/27/21
Fly Intel: Top five analyst upgrades
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

  • 02
    Dec
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPX S&P 500
/

+

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPX S&P 500
/

+

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

Hot Stocks
Salesforce co-CEO Benioff: I'm never leaving the company » 18:21
11/30/21
11/30
18:21
11/30/21
18:21
CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

In an interview on…

In an interview on CNBC's Mad Money, Marc Benioff said, "I love Salesforce and I'm never leaving. It's my life's pursuit." The core of the business is growing very quickly, faster than expected, he noted. "We're very excited about the future." Co-CEO Bret Taylor said the core of Salesforce's business has "never been stronger."

ShowHide Related Items >><<
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
11/23/21 Citi
Salesforce price target raised to $308 from $280 at Citi
11/22/21 Atlantic Equities
Atlantic Equities assumes 'low-risk' Salesforce at Overweight
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

General news
October farm prices up 20.0% vs. last year  18:01
11/30/21
11/30
18:01
11/30/21
18:01
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
October farm prices down 1.7% vs. last month  18:01
11/30/21
11/30
18:01
11/30/21
18:01
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
IBM acquires SXiQ, terms not disclosed » 18:01
11/30/21
11/30
18:01
11/30/21
18:01
IBM

IBM

$117.14 /

-1.36 (-1.15%)

IBM announced the…

IBM announced the acquisition of SXiQ, an Australian digital transformation services company specializing in cloud applications, cloud platforms and cloud cybersecurity. This news further advances IBM's hybrid cloud and AI strategy by helping enterprises modernize and transform complex mission-critical applications on multiple clouds and platforms. Financial details were not disclosed.

ShowHide Related Items >><<
IBM IBM
$117.14 /

-1.36 (-1.15%)

IBM IBM
$117.14 /

-1.36 (-1.15%)

10/28/21 Credit Suisse
IBM assumed with an Outperform at Credit Suisse
10/21/21 Morgan Stanley
IBM's Q3 'a pause on the path to improving growth,' says Morgan Stanley
10/06/21 Evercore ISI
IBM removed from Tactical Outperform list at Evercore ISI
10/05/21 Credit Suisse
IBM price target raised to $176 from $167 at Credit Suisse
IBM IBM
$117.14 /

-1.36 (-1.15%)

IBM IBM
$117.14 /

-1.36 (-1.15%)

IBM IBM
$117.14 /

-1.36 (-1.15%)

IBM IBM
$117.14 /

-1.36 (-1.15%)

Hot Stocks
Merck says FDA panel vote on COVID antiviral a 'positive outcome' » 17:53
11/30/21
11/30
17:53
11/30/21
17:53
MRK

Merck

$74.87 /

-0.005 (-0.01%)

Merck and Ridgeback…

Merck and Ridgeback Biotherapeutics provided a statement at the conclusion of the U.S. Food and Drug Administration's Antimicrobial Drugs Advisory Committee regarding the Emergency Use Authorization application for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild to moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progressing to severe COVID-19 and/or hospitalization. The Advisory Committee voted 13-10 that the known and potential benefits of molnupiravir outweigh its known and potential risks for the treatment of mild to moderate COVID-19 in high risk adult patients who are within five days of symptom onset. The FDA is not bound by the committee's guidance but takes its advice into consideration. "The positive outcome of today's FDA Advisory Committee meeting, following a comprehensive review of molnupiravir, including the compelling data from the MOVe-OUT study demonstrating a significant reduction in hospitalizations and deaths, is a critical step toward bringing this promising oral medicine for COVID-19 to appropriate patients in the U.S. With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine," said Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories. "We are grateful to the members of the Advisory Committee who reviewed our application, as well as to the patients and investigators who participated in our clinical trials, and we will continue to work with the FDA as the agency completes its review."

ShowHide Related Items >><<
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

Hot Stocks
Kyndryl Holdings CEO buys $997K, CFO buys $248K in common stock » 17:53
11/30/21
11/30
17:53
11/30/21
17:53
KD

Kyndryl Holdings

$15.77 /

-0.54 (-3.31%)

In regulatory filings,…

In regulatory filings, Kyndryl Holdings disclosed that its CEO Martin Schroeter bought 58.3K shares of common stock for $997K and CFO David Wyshner bought 14.9K shares for $248.4K on November 29th, boosting their respective holdings by 10% and 6%. Shares of Kyndryl Holdings are up 2.8% in after-hours trading at $16.24.

ShowHide Related Items >><<
KD Kyndryl Holdings
$15.77 /

-0.54 (-3.31%)

KD Kyndryl Holdings
$15.77 /

-0.54 (-3.31%)

11/14/21 Evercore ISI
Kyndryl Holdings initiated with an In Line at Evercore ISI
KD Kyndryl Holdings
$15.77 /

-0.54 (-3.31%)

Upgrade
Asur upgraded to Neutral from Sell at Goldman Sachs » 17:50
11/30/21
11/30
17:50
11/30/21
17:50
ASR

Asur

$182.61 /

+3.38 (+1.89%)

Goldman Sachs analyst…

Goldman Sachs analyst Bruno Amorim upgraded Asur to Neutral from Sell with a price target of $225, up from $179, as part of a broader research note on Mexico transportation names. The analyst cites faster than expected recovery in international traffic so far this year, but also believes that the stock is currently fairly priced, adding that he sees better upside elsewhere in his coverage.

ShowHide Related Items >><<
ASR Asur
$182.61 /

+3.38 (+1.89%)

ASR Asur
$182.61 /

+3.38 (+1.89%)

11/30/21 Goldman Sachs
OMA upgraded to Buy from Neutral at Goldman Sachs
10/13/21 Citi
Asur price target raised to $218 from $191 at Citi
06/15/21 Scotiabank
Asur upgraded to Sector Perform from Underperform at Scotiabank
06/14/21 HSBC
Asur price target raised to MXN 389 from MXN 316 at HSBC
Upgrade
OMA upgraded to Buy from Neutral at Goldman Sachs » 17:47
11/30/21
11/30
17:47
11/30/21
17:47
OMAB

OMA

$45.24 /

-0.95 (-2.06%)

, ASR

Asur

$182.61 /

+3.38 (+1.89%)

, PAC

GAP Airports

$115.25 /

-0.375 (-0.32%)

Goldman Sachs analyst…

Goldman Sachs analyst Bruno Amorim upgraded OMA (OMAB) to Buy from Neutral with a price target of $65, up from $55. The analyst expects a catch up in traffic recovery from mid-2022 onwards as industrial business traffic recovers in Mexico, and as the company further benefits from the growth in traffic. Amorim added that he believes recent underperformance of OMA compared to Asur (ASR) and GAP (PAC) has been driven by traffic underperformance he anticipates will revert in the upcoming quarters.

ShowHide Related Items >><<
PAC GAP Airports
$115.25 /

-0.375 (-0.32%)

ASR Asur
$182.61 /

+3.38 (+1.89%)

OMAB OMA
$45.24 /

-0.95 (-2.06%)

06/15/21 Scotiabank
OMA downgraded to Underperform from Sector Perform at Scotiabank
06/14/21 HSBC
OMA price target raised to MXN 158 from MXN 148 at HSBC
06/11/21 Citi
OMA reinstated with a Neutral at Citi
04/11/21 Goldman Sachs
OMA price target lowered to $49 from $50 at Goldman Sachs
ASR Asur
$182.61 /

+3.38 (+1.89%)

10/13/21 Citi
Asur price target raised to $218 from $191 at Citi
06/15/21 Scotiabank
Asur upgraded to Sector Perform from Underperform at Scotiabank
06/14/21 HSBC
Asur price target raised to MXN 389 from MXN 316 at HSBC
04/11/21 Goldman Sachs
Asur downgraded to Sell from Neutral at Goldman Sachs
PAC GAP Airports
$115.25 /

-0.375 (-0.32%)

11/08/21 Barclays
GAP Airports downgraded to Equal Weight from Overweight at Barclays
10/20/21 Citi
GAP Airports price target raised to $153 from $151 at Citi
07/29/21 Scotiabank
GAP Airports upgraded to Outperform from Sector Perform at Scotiabank
07/08/21 UBS
GAP Airports upgraded to Neutral from Sell at UBS
OMAB OMA
$45.24 /

-0.95 (-2.06%)

Hot Stocks
CTI BioPharma announces extension of FDA review period for pacritinib NDA » 17:33
11/30/21
11/30
17:33
11/30/21
17:33
CTIC

CTI BioPharma

$2.23 /

-0.43 (-16.17%)

CTI BioPharma announced…

CTI BioPharma announced the FDA has extended the review period for the new drug application, or NDA, for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis, or MF. The Prescription Drug User Fee Act action date has been extended by three months to February 28, 2022. In Q2, the FDA granted priority review for CTI's NDA for patients with myelofibrosis with a PDUFA date of November 30. In the course of product labeling discussions, the FDA requested additional clinical data, which was submitted to the agency on November 24. Earlier, the FDA informed the company that it considers the data submission to constitute a "major amendment" to the NDA and therefore the PDUFA date has been extended by three months to provide additional time for a full review of the submission. At the current time, CTI is not aware of any major deficiencies in the application.

ShowHide Related Items >><<
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
05/06/21
Fly Intel: Top five analyst initiations
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

  • 01
    Apr
Syndicate
Soluna Holdings files to sell 3.55M shares of common stock for holders  17:32
11/30/21
11/30
17:32
11/30/21
17:32
SLNH

Soluna Holdings

$12.04 /

-0.51 (-4.06%)

 
ShowHide Related Items >><<
SLNH Soluna Holdings
$12.04 /

-0.51 (-4.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.